FDMT Operating Cash Flow (Statement)
4D Molecular Therapeutics Inc · Operating Cash Flow (Statement)
FDMT Operating Cash Flow (Statement)
Latest reported-$156.07Mperiod ending
FDMT TTM Cash from Operations (-$16.25M → -$156.07M)
TTM operating cash flow (statement)
High-resolution chart · PNG
FDMT operating cash flow (statement) history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -156,071,000 | |
| -129,449,000 | |
| -109,082,000 | |
| -183,496,000 | |
| -166,389,000 | |
| -153,255,000 | |
| -134,585,000 | |
| -113,372,000 | |
| -85,152,000 | |
| -76,974,000 | |
| -75,792,000 | |
| -73,356,000 | |
| -93,202,000 | |
| -91,041,000 | |
| -86,685,000 | |
| -86,307,000 | |
| -81,011,000 | |
| -77,312,000 | |
| -69,134,000 | |
| -64,797,000 | |
| -62,447,000 | |
| -52,411,000 | |
| -50,909,000 | |
| -42,096,000 | |
| -39,582,000 | |
| -41,997,000 | |
| -36,711,000 | |
| -32,940,000 | |
| -26,998,000 | |
| -21,625,000 | |
| -16,252,000 |